Edition:
United States

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

2.49USD
13 Jul 2018
Change (% chg)

$0.06 (+2.47%)
Prev Close
$2.43
Open
$2.43
Day's High
$2.52
Day's Low
$2.39
Volume
5,492
Avg. Vol
29,761
52-wk High
$5.55
52-wk Low
$1.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 7.85 -0.146
FY 2017 Dec '17 20.64 0.220
Sep '17 5.11 -0.284
Jun '17 6.20 -0.405
Mar '17 6.21 -0.607
FY 2016 Dec '16 6.22 -0.602
Sep '16 5.92 -0.766
Jun '16 6.66 -0.914
Mar '16 6.35 -0.900
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 7.21 9.43 6.00 5.74
Quarter Ending Dec-18 3 7.16 9.27 6.00 5.74
Year Ending Dec-18 3 29.24 35.51 25.80 40.47
Year Ending Dec-19 3 25.65 26.64 24.80 81.71
Earnings (per share)
Quarter Ending Sep-18 3 -0.22 -0.11 -0.37 -0.51
Quarter Ending Dec-18 3 -0.23 -0.13 -0.36 -0.49
Year Ending Dec-18 3 -0.83 -0.52 -1.25 -1.58
Year Ending Dec-19 3 -1.00 -0.65 -1.50 0.16
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.48 32.76
P/E High - Last 5 Yrs. -- 298.85 45.44
P/E Low - Last 5 Yrs. -- 91.59 24.26
Beta 2.74 0.93 0.89
Price to Sales (TTM) 6.68 112.69 5.73
Price to Book (MRQ) -- 14.09 5.45
Price to Tangible Book (MRQ) -- 14.67 7.05
Price to Cash Flow (TTM) -- 72.72 23.29
% Owned Institutions 73.35 14.42 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.38 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -7.07 408.74 8.01
Sales (TTM) vs TTM 1 Yr. Ago 0.01 80.05 5.64
Sales - 5 Yr. Growth Rate -4.35 32.09 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 48.37 29.06 20.60
EPS (TTM) vs TTM 1 Yr. Ago 28.37 -- --
EPS - 5 Yr. Growth Rate -- 39.56 10.66
Capital Spending - 5 Yr. Growth Rate -12.42 40.05 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 3.39 5.50 3.03
LT Debt to Equity (MRQ) -- 25.57 12.39
Total Debt to Equity (MRQ) -- 27.28 16.72
Interest Coverage (TTM) -- -101.33 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.25 54.37
Gross Margin - 5 Yr. Avg. -- 50.67 52.17
EBITD Margin (TTM) -335.43 -- --
EBITD - 5 Yr. Avg -181.75 -588.18 10.81
Operating Margin (TTM) -352.49 -734.89 4.57
Operating Margin - 5 Yr. Avg. -186.73 -609.81 6.23
Pre-Tax Margin (TTM) -350.45 -708.96 5.43
Pre-Tax Margin - 5 Yr. Avg. -186.42 -613.30 6.67
Net Profit Margin (TTM) -350.52 -710.36 1.73
Net Profit Margin - 5 Yr. Avg. -187.38 -616.33 2.94
Effective Tax Rate (TTM) -- 23.27 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.59 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 201,188 23,066,163 860,414,722
Net Income/Employee (TTM) -705,205 3,124,085 101,211,891
Receivable Turnover (TTM) 12.24 20.78 5.87
Inventory Turnover (TTM) -- 2.48 3.41
Asset Turnover (TTM) 0.15 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -53.56 0.33 11.14
Return on Assets - 5 Yr. Avg. -27.30 3.75 12.40
Return on Investment (TTM) -75.79 2.29 14.61
Return on Investment - 5 Yr. Avg. -34.15 2.93 16.14
Return on Equity (TTM) -- 3.86 16.34
Return on Equity - 5 Yr. Avg. -- 4.40 17.40
  1 Year 3 Year 5 Year
Sales % -2.88 -12.68 -4.35
EPS (TTM) % -10.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OncoMed Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.11 -6.45 29 53
13 Week 27.49 21.28 80 66
26 Week -50.23 -54.01 10 79
52 Week -61.28 -67.18 12 52
YTD -43.45 -50.34 14 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 65.91%
# of Holders: 84
Total Shares Held: 25,329,765
3 Mo. Net Change: 59,846
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.